The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

På svenska

Author

  • Andreas Agathangelidis
  • Nikos Darzentas
  • Anastasia Hadzidimitriou
  • Xavier Brochet
  • Fiona Murray
  • Xiao-Jie Yan
  • Zadie Davis
  • Ellen J. van Gastel-Mol
  • Cristina Tresoldi
  • Charles C. Chu
  • Nicola Cahill
  • Veronique Giudicelli
  • Boris Tichy
  • Lone Bredo Pedersen
  • Letizia Foroni
  • Lisa Bonello
  • Agnieszka Janus
  • Karin Smedby
  • Achilles Anagnostopoulos
  • Helene Merle-Beral
  • Nikolaos Laoutaris
  • Gunnar Juliusson
  • Paola Francia di Celle
  • Sarka Pospisilova
  • Jesper Jurlander
  • Christian Geisler
  • Athanasios Tsaftaris
  • Marie-Paule Lefranc
  • Anton W. Langerak
  • David Graham Oscier
  • Nicholas Chiorazzi
  • Chrysoula Belessi
  • Frederic Davi
  • Richard Rosenquist
  • Paolo Ghia
  • Kostas Stamatopoulos
Show all

Summary, in English

Mounting evidence indicates that grouping of chronic lymphocytic leukemia (CLL) into distinct subsets with stereotyped BCRs is functionally and prognostically relevant. However, several issues need revisiting, including the criteria for identification of BCR stereotypy and its actual frequency as well as the identification of "CLL-biased" features in BCR Ig stereotypes. To this end, we examined 7596 Ig VH (IGHV-IGHD-IGHJ) sequences from 7424 CLL patients, 3 times the size of the largest published series, with an updated version of our purpose-built clustering algorithm. We document that CLL may be subdivided into 2 distinct categories: one with stereotyped and the other with nonstereotyped BCRs, at an approximate ratio of 1: 2, and provide evidence suggesting a different ontogeny for these 2 categories. We also show that subset-defining sequence patterns in CLL differ from those underlying BCR stereotypy in other B-cell malignancies. Notably, 19 major subsets contained from 20 to 213 sequences each, collectively accounting for 943 sequences or one-eighth of the cohort. Hence, this compartmentalized examination of VH sequences may pave the way toward a molecular classification of CLL with implications for targeted therapeutic interventions, applicable to a significant number of patients assigned to the same subset. (Blood. 2012;119(19):4467-4475)

Publishing year

2012

Language

English

Pages

4467-4475

Publication/Series

Blood

Volume

119

Issue

19

Document type

Journal article

Publisher

American Society of Hematology

Topic

  • Hematology

Status

Published

ISBN/ISSN/Other

  • ISSN: 1528-0020